Organization
Nektar Therapeutics
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Nektar Therapeutics
... Holzer & Holzer, LLC is investigating whether Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ: NKTR) complied with the federal securities laws. ...
... (http://www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ: NKTR) and certain of its officers and ...
... PR Newswire Nektar Therapeutics (Nasdaq: NKTR) today announced that ten clinical and preclinical data presentations across ...
... Nektar Therapeutics (Nasdaq: NKTR) today announced that it has appointed Karin Eastham as an ...
... identify the next wave of medicines across neuroscience and immuno-oncology, and Nektar Therapeutics (Nasdaq: NKTR) announced today that the companies are expanding their ongoing research ...
... led the pre-approval inspections that brought Botox (Allergan), Myoblock (Elan), and Exubera (Nektar-Pfizer) to the market and supported, prepared, and contributed to multiple pre-approval activities ...
Subscribe now for full coverage on Nektar Therapeutics
Start My Free Trial